Skip to main content

Table 2 Risk groups based on THRI score

From: Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study

THRI score All patients (n = 520) HCC (n = 76) Non-HCC (n = 444)
< 120, n (%) 23 (4.4) 0 (0.0) 23 (5.2)
120–240, n (%) 248 (47.7) 20 (26.3) 228 (51.4)
> 240, n (%) 249 (47.9) 56 (73.7) 193 (43.5)